Skip to content

Defining the Conjunctival Staining Method: Instillation Volume and Time Course to Assess Staining With Lissamine Green

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00768898
Enrollment
30
Registered
2008-10-08
Start date
2008-08-31
Completion date
Unknown
Last updated
2012-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conjunctival Staining

Keywords

conjunctival, staining

Brief summary

The purpose of this study is to determine the correct volume of lissamine green to use when assessing conjunctival staining, and to determine the time course needed to evaluate conjunctival staining after lissamine green has been instilled in the eye.

Interventions

OTHER2.5/5.0/10.0 µL lissamine green

vital stain solution

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* conjunctival staining

Exclusion criteria

* ocular pathology

Design outcomes

Primary

MeasureTime frameDescription
Conjunctival Staining at 1 Minute1 minute after instillationLissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
Conjunctival Staining at 2 Minutes2 minutes after instillationLissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
Conjunctival Staining at 3 Minutes3 minutes after instillationLissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
Conjunctival Staining at 4 Minutes4 minutes after instillationLissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
Conjunctival Staining at 5 Minutes5 minutes after instillationLissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.

Countries

United States

Participant flow

Recruitment details

30 subjects with conjunctival staining and no other ocular pathology were recruited and enrolled.

Pre-assignment details

This reporting group includes all enrolled participants.

Participants by arm

ArmCount
Overall
All enrolled participants
30
Total30

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyHeadache1
Overall StudyUnrelated injury1

Baseline characteristics

CharacteristicOverall
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 300 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 300 / 30

Outcome results

Primary

Conjunctival Staining at 1 Minute

Lissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.

Time frame: 1 minute after instillation

Population: Analysis conducted per protocol. All subjects participated in each arm/group.

ArmMeasureValue (MEAN)Dispersion
2.5 Microliters Lissamine GreenConjunctival Staining at 1 Minute3.29 Units on a scaleStandard Deviation 1.58
5.0 Microliters Lissamine GreenConjunctival Staining at 1 Minute3.67 Units on a scaleStandard Deviation 1.72
10.0 Microliters Lissamine GreenConjunctival Staining at 1 Minute3.98 Units on a scaleStandard Deviation 1.75
Primary

Conjunctival Staining at 2 Minutes

Lissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.

Time frame: 2 minutes after instillation

Population: Analysis conducted per protocol. All subjects participated in each arm/group.

ArmMeasureValue (MEAN)Dispersion
2.5 Microliters Lissamine GreenConjunctival Staining at 2 Minutes3.67 Units on a scaleStandard Deviation 1.75
5.0 Microliters Lissamine GreenConjunctival Staining at 2 Minutes4.29 Units on a scaleStandard Deviation 1.76
10.0 Microliters Lissamine GreenConjunctival Staining at 2 Minutes4.64 Units on a scaleStandard Deviation 1.75
Primary

Conjunctival Staining at 3 Minutes

Lissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.

Time frame: 3 minutes after instillation

Population: Analysis conducted per protocol. All subjects participated in each arm/group.

ArmMeasureValue (MEAN)Dispersion
2.5 Microliters Lissamine GreenConjunctival Staining at 3 Minutes3.02 Units on a scaleStandard Deviation 1.6
5.0 Microliters Lissamine GreenConjunctival Staining at 3 Minutes3.88 Units on a scaleStandard Deviation 1.85
10.0 Microliters Lissamine GreenConjunctival Staining at 3 Minutes4.12 Units on a scaleStandard Deviation 1.92
Primary

Conjunctival Staining at 4 Minutes

Lissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.

Time frame: 4 minutes after instillation

Population: Analysis conducted per protocol. All subjects participated in each arm/group.

ArmMeasureValue (MEAN)Dispersion
2.5 Microliters Lissamine GreenConjunctival Staining at 4 Minutes2.48 Units on a scaleStandard Deviation 1.63
5.0 Microliters Lissamine GreenConjunctival Staining at 4 Minutes3.14 Units on a scaleStandard Deviation 1.75
10.0 Microliters Lissamine GreenConjunctival Staining at 4 Minutes3.69 Units on a scaleStandard Deviation 1.81
Primary

Conjunctival Staining at 5 Minutes

Lissamine green was instilled in each eye. Conjunctival staining was assessed by the investigator in the nasal and temporal sections. The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe. The nasal and temporal scores were summed, for a possible score of 0-10 for each eye. Each subject was represented by a single eye, referred to as the study eye. The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.

Time frame: 5 minutes after instillation

Population: Analysis conducted per protocol. All subjects participated in each arm/group.

ArmMeasureValue (MEAN)Dispersion
2.5 Microliters Lissamine GreenConjunctival Staining at 5 Minutes2.12 Units on a scaleStandard Deviation 1.48
5.0 Microliters Lissamine GreenConjunctival Staining at 5 Minutes2.67 Units on a scaleStandard Deviation 1.78
10.0 Microliters Lissamine GreenConjunctival Staining at 5 Minutes3.10 Units on a scaleStandard Deviation 1.64

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026